Detalhe da pesquisa
1.
Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naïve patients.
J Viral Hepat
; 28(10): 1381-1391, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228855
2.
Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsets.
J Ethnopharmacol
; 328: 118072, 2024 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508431
3.
The efficacy and safety of adding on or switching to peginterferon α-2b in HBeAg-positive chronic hepatitis B patients with long-term entecavir treatment: a multicentre randomised controlled trial.
Aliment Pharmacol Ther
; 56(9): 1394-1407, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128636